Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU4-55P (RNA, U4 small nuclear 55, pseudogene) is a non-coding RNA pseudogene in the human genome that resembles the active genes encoding U4 small nuclear RNA, a critical spliceosomal RNA. Unlike functional snRNA genes, such as RNU4-2, which participate in mRNA splicing and are associated with neurodevelopmental disorders when mutated, RNU4-55P is a remnant or duplicate generated via retrotransposition and does not transcribe a functional RNA or protein product. Pseudogenes like RNU4-55P are prevalent in the human genome and may retain sequence similarity to functional snRNAs but lack biological activity or disease association[1][4][6]. RNU4-55P is not a receptor, enzyme, transporter, transcription factor, or any typical druggable target. It should not be confused with functional U4 snRNA genes (RNU4-2), which are important for spliceosome assembly and human neurodevelopmental disorders[5]. The inclusion of RNU4-55P as a therapeutic target or biomarker is incorrect and misleading[1][4].
None applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 55, pseudogene (RNU4-55P).